Cancer research, long protected, feels ‘devastating’ effects under Trump Budget cuts and research delays threaten to reverse progress on what had been a bipartisan cause

https://www.statnews.com/2025/03/24/trump-cancer-research-funding-cuts-patients-researchers-worried/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz--ZOGg89GvAE4xOquxm7kefv2jzOtVdDwJ7Qq_eCus8l8PRKm3jiF-YDNrCVmbgxzPR7LiCXUvoUQpDV79jz5GgPLya9A&_hsmi=353208413&utm_content=353208413&utm_source=hs_email Over the last three decades, an abundance of federal funding has brought cancer science to its peak. New discoveries are accelerating, and the stage is set to introduce a dizzying number of advances over the next 10 years. And when President Trump accepted the Republican nomination for the Oval Office last year, he promised he was the leader who would “get the cure to cancer, Alzheimer’s, and other things.” But STAT’s Angus Chen reviewed a draft congressional budget that leaves no funds allocated specifically to kidney, pancreatic, lung, or brain cancer and reduces funding for breast, ovarian, and prostate cancer. He also spoke to more than a dozen experts who said that the administration’s actions could bring about long-lasting damage to cancer research — and that patients will die when they otherwise might have lived. “Sometimes, we want to call out people who are cheering these cuts,” cancer patient Natalie Phelps told Angus. “I don’t know if they realize or if they’re willing to accept and look me in the eye and know that means I potentially won’t be around very long.”